BB&T Securities’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-5,543
| Closed | -$254K | – | 1563 |
|
|
2018
Q3 | $254K | Buy |
+5,543
| New | +$246K | ﹤0.01% | 1389 |
|
|
2018
Q1 | – | Sell |
-5,990
| Closed | -$205K | – | 1540 |
|
|
2017
Q4 | $205K | Sell |
5,990
-5,348
| -47% | -$180K | ﹤0.01% | 1340 |
|
|
2017
Q3 | $410K | Sell |
11,338
-188,765
| -94% | -$5.38M | 0.01% | 1041 |
|
|
2017
Q2 | $5.17M | Sell |
200,103
-705,107
| -78% | -$15M | 0.08% | 321 |
|
|
2017
Q1 | $17.4M | Buy |
905,210
+7,754
| +0.9% | +$137K | 0.24% | 106 |
|
|
2016
Q4 | $18.5M | Hold |
897,456
| – | – | 0.27% | 101 |
|
|
2016
Q3 | $18.5M | Buy |
897,456
+238,285
| +36% | +$6.04M | 0.28% | 98 |
|
|
2016
Q2 | $20.2M | Buy |
659,171
+25,478
| +4% | +$885K | 0.31% | 88 |
|
|
2016
Q1 | $23.7M | Buy |
633,693
+2,148
| +0.3% | +$80.9K | 0.39% | 68 |
|
|
2015
Q4 | $27.3M | Sell |
631,545
-99,901
| -14% | -$4.22M | 0.57% | 57 |
|
|
2015
Q3 | $27.4M | Buy |
731,446
+13,795
| +2% | +$490K | 0.6% | 51 |
|
|
2015
Q2 | $24.4M | Buy |
717,651
+113,130
| +19% | +$3.85M | 0.52% | 57 |
|
|
2015
Q1 | $214M | Buy |
604,521
+10,515
| +2% | +$376K | 0.47% | 59 |
|
|
2014
Q4 | $202M | Buy |
594,006
+7,460
| +1% | +$265K | 0.46% | 58 |
|
|
2014
Q3 | $226M | Buy |
586,546
+3,046
| +0.5% | +$114K | 0.53% | 55 |
|
|
2014
Q2 | $227M | Sell |
583,500
-131,537
| -18% | -$4.89M | 0.54% | 53 |
|
|
2014
Q1 | $244M | Sell |
715,037
-171,276
| -19% | -$5.31M | 0.63% | 49 |
|
|
2013
Q4 | $186M | Buy |
886,313
+63,120
| +8% | +$1.6M | 0.51% | 53 |
|
|
2013
Q3 | $193M | Buy |
823,193
+82,768
| +11% | +$2.35M | 0.6% | 52 |
|
|
2013
Q2 | $199K | Buy |
+740,425
| New | +$21.5M | 0.65% | 49 |
|
Other funds holding MYGN
FCM
CCM
